Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026

Company Overview - Vaxart, Inc. is a clinical-stage biotechnology company focused on developing oral recombinant vaccines using its proprietary delivery platform [3] - The company aims to create vaccines that can be administered in pill form, which can be stored and shipped without refrigeration, thus eliminating the risk of needle-stick injuries [3] - Vaxart's current development programs include vaccines targeting coronavirus, norovirus, influenza, and a therapeutic vaccine for human papillomavirus (HPV) [3] Upcoming Event - Vaxart will participate in the Global BioInnovation Forum, a virtual event featuring senior leaders in life sciences and health innovation [1] - Key speakers at the event will include Steven Lo (CEO), Sean Tucker (Founder and CSO), and James F. Cummings (CMO) [2] - The event is scheduled for January 13, 2026, at 11:30 AM PT, and the webcast will be available for 30 days post-event on the company's investor relations website [2]